---
layout: page
title: Publications
permalink: /Publications/
---

From recent - 2013
* First author publications 

1.	Neelamraju Y.*, E. Gjini, S. Chhangawala, H. Fan, S. He, C. B. Jing, A. T. Nguyen, S. Prajapati, C. Sheridan, Y. Houvras, A. Melnick, A. T. Look and F. E. Garrett-Bakelman (2023). "Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome." [Read it here->](https://pubmed.ncbi.nlm.nih.gov/37937078/)

2. Rapaport, F.*, K. Seier*, Y. Neelamraju*, D. Hassane, T. Baslan, D. T. Gildea, S. Haddox, T. Lee, H. M. Murdock, C. Sheridan, A. Thurmond, L. Wang, M. Carroll, L. D. Cripe, H. Fernandez, C. E. Mason, E. Paietta, G. J. Roboz, Z. Sun, M. S. Tallman, Y. Zhang, M. Gonen, R. Levine, A. M. Melnick, M. Kleppe and F. E. Garrett-Bakelman (2022). "Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999." [Read it here][Pointing Right](images/pointing-right.png)(https://pubmed.ncbi.nlm.nih.gov/37407550/)

3. Barreyro, L., A. M. Sampson, C. Ishikawa, K. M. Hueneman, K. Choi, M. A. Pujato, S. Chutipongtanate, et al. "Blocking Ube2n Abrogates Oncogenic Immune Signaling in Acute Myeloid Leukemia."

4.	Rapaport F, Neelamraju Y, Baslan T, Hassane D, Gruszczynska A, Robert de Massy M, et al. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia. Leukemia. 2021.

5. Olson TL, Cheon H, Xing JC, Olson KC, Paila U, Hamele CE, et al. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias. Blood. 2021;138(8):662-73.

6.	Abshiru NA, Sikora JW, Camarillo JM, Morris JA, Compton PD, Lee T, et al. Targeted detection and quantitation of histone modifications from 1,000 cells. PLoS One. 2020;15(10):e0240829.

7.	Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, et al. Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways. EMBO Rep. 2019;20(2).

8.	Neelamraju Y, Gonzalez-Perez A, Bhat-Nakshatri P, Nakshatri H, Janga SC. Mutational landscape of RNA-binding proteins in human cancers. RNA Biol. 2018;15(1):115-29.

9.	Nishtala S, Neelamraju Y, Janga SC. Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks. Sci Rep. 2016; 6:25711.

10.	Neelamraju Y, Hashemikhabir S, Janga SC. The human RBPome: from genes and proteins to human disease. J Proteomics. 2015;127(Pt A):61-70.

11.	Hashemikhabir S, Neelamraju Y, Janga SC. Database of RNA binding protein expression and disease dynamics (READ DB). Database (Oxford). 2015;2015: bav072.

12.	Gokmen-Polar Y, Vladislav IT, Neelamraju Y, Janga SC, Badve S. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers. Sci Rep. 2015; 5:8765.

13.	Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu X, Nallamothu G, Janga SC, et al. Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer. Mod Pathol. 2015;28(5):677-85.

14.	Chaturvedi P, Neelamraju Y, Arif W, Kalsotra A, Janga SC. Uncovering RNA binding proteins associated with age and gender during liver maturation. Sci Rep. 2015; 5:9512.



